Snowball logo
logo
6535

Lumosa Therapeutics Co. Ltd.

6535 β€’ TWO
NT$86.10-NT$1.80Β  (2.05%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
17.3626.6456.9239.1535.8331.42
COGS
7.47312.0815.4421.4413.9612.92
Gross Profit
9.88914.5641.4817.7121.8718.5
Operating Expenses & Income
Operating Income
96.21(504.3)(249.9)(356.9)(333.5)(293.6)
Total Operating Expenses
440.2320.5417.1396.1369.3325
R&D Expenses
406280.5369.3322.9304.4261
Selling General & Admin Expenses
24.3623.5526.1151.851.0151.07
Earnings from Continuing Operations
Interest Expense
(0.26)(0.149)(0.047)(0.187)(0.201)(0.167)
Interest Income
3.4575.3210.499.43116.0714.16
Income Tax Expense
-0.0360.248---
Net Income
Net Income
95.95(494.7)(238)(424.8)(340.5)(356)
Supplemental
EBIT
96.21(504.3)(249.9)---
EBITDA
128.3(482.1)(226.5)---
In millions of TWD, except % and values per 1 share